Pneumococcal surface proteins

A pneumococcal and protein technology, applied in antibacterial drugs, bacterial antigen components, allergic diseases, etc., can solve problems such as easy deamination

Pending Publication Date: 2021-11-09
THE UNIV OF TOKYO +1
View PDF14 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, PspA derived from the D39 strain is prone to deamination at a pH near neutral, and has a problem in terms of stability.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pneumococcal surface proteins
  • Pneumococcal surface proteins
  • Pneumococcal surface proteins

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0062] 1. Native PAGE

[0063]Various PspA proteins, PspA 1-1 (SEQ ID NO: 5), PspA 1-2 (SEQ ID NO: 6), PspA 1-3 (SEQ ID NO: 4) and PspA 1-3LB (SEQ ID NO: 3) were expressed in Escherichia coli Medium expression (refer to WO2018102774 for details). The expressed PspA protein was extracted non-denaturingly by conventional methods, and purified using ion-exchange chromatography, butyl agarose, etc. until it became homogeneous in LDS (Lithium Dodecyl Sulfate)-PAGE.

[0064] First, PspA 1-3 molecules were suspended in 2 mg / ml PBS immediately after purification and washed with 0.5M NaH 2 PO 4 or 0.5MNa 2 HP 4 The pH was adjusted to a predetermined pH (pH6.5, pH7.0, pH7.5, pH8.0, and pH8.5), and stored at 25°C for a predetermined time (1 day, 2 days, and 5 days). 10 μl (1.0 μg / lane) of each sample was electrophoresed by Native PAGE at 200 V for 60 minutes, and stained with Coomassie blue (BioRad). It should be noted that the gel used was 7.5% Mini-Protein TGX Gel12well (BioRad),...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to view more

Abstract

The present invention provides D39-derived mutant PspA that does not undergo deamination and maintains molecular stability even at near-neutral pH. Specifically, the present invention is the following protein (a) or (b). (a) A protein that includes the amino acid sequence represented by sequence no. 2 and that has pneumococcus vaccine antigenic activity, and a protein substantially the same as said protein; and (b) a protein that includes a portion of the amino acid sequence represented by sequence no. 2, said portion including aspartic acid at position 254, and that has pneumococcus vaccine antigenic activity, and a protein substantially the same as said protein.

Description

technical field [0001] The present invention relates to pneumococcal surface protein A (PspA) and vaccines comprising PspA. Background technique [0002] Pneumococcus is a clinically important pathogen of upper respiratory tract infection alongside influenza virus. It is complicated by otitis media to pneumonia, bacteremia, meningitis, etc., and causes serious illness including death in children and adults. [0003] In recent years, 7-, 10-, and 13-valent polysaccharide-conjugated pneumococcal vaccines (PCV (pneumococcal conjugate vaccine) 7, PCV10 and PCV13), administered by intramuscular injection. However, this polysaccharide-based vaccine hardly induces an immune response in children due to the weak immunogenicity of the T-cell-independent polysaccharide, and also shows an infection defense effect only against capsular serotype pneumococci. Furthermore, since intramuscular injection of vaccines mainly induces systemic anti-IgG antibodies, these vaccines have problems s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/09A61P11/00A61P37/04C07K14/315C12N15/31
CPCA61P11/00C07K14/315A61K39/092A61P31/04A61K2039/575A61K2039/57A61K2039/54A61K2039/545C07K14/3156
Inventor 幸义和中桥理佳清野宏
Owner THE UNIV OF TOKYO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap